Expression and role of phosphodiesterase 3 in human squamous cell carcinoma KB cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Expression and role of phosphodiesterase 3 in human squamous cell carcinoma KB cells

Published:2002-09 Issue:8 Volume:13 Page:875-880
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:Anti-Cancer Drugs

Author:

Shimizu Kasumi,Murata Taku,Okumura Kenya,Manganiello Vincent C,Tagawa Toshiro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference32 articles.

1. Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck

2. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck

3. Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PEG-200: A versatile green solvent assisted catalyst-free one-pot three-component synthesis of functionalised N-amino-3-cyano-2-pyridone;Results in Chemistry;2023-01

2. Molecular docking and anticancer evaluation of some newly synthesized 4-aryl-2-(2-oxopropoxy)-6-(cyclohexyl)nicotinonitrile and their furo[2,3-b]pyridine derivatives;Journal of Molecular Structure;2022-09

3. Study of supramolecular self-assembly of pyridone and dihydropyridone co-crystal: Synthesis, crystal structure, Hirshfeld surface, DFT and molecular docking studies;Journal of Molecular Structure;2021-07

4. Phosphodiesterase 3A Represents a Therapeutic Target that Drives Stem Cell–like Property and Metastasis in Breast Cancer;Molecular Cancer Therapeutics;2019-12-23

5. An efficient and ecofriendly synthesis of highly functionalized pyridones via a one-pot three-component reaction;RSC Advances;2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3